|
Tissue Engineering
Chondrogenic Differentiation of Mesenchymal Stem Cells Isolated from Patients in Late Adulthood: The Optimal Conditions of Growth Factors
To cite this article:
Gun-Il Im, Nam-Hee Jung, Suk-Kee Tae.
Tissue Engineering.
March 2006,
12(3): 527-536.
doi:10.1089/ten.2006.12.527.
Gun-Il Im, M.D.Department of Orthopedics, Dongguk University International Hospital, Goyang, Korea. Nam-Hee Jung, M.S.Department of Orthopedics, Dongguk University International Hospital, Goyang, Korea. Suk-Kee Tae, M.D.Department of Orthopedics, Dongguk University International Hospital, Goyang, Korea. There is a controversy about the capacity of the mesenchymal stem cells (MSCs) from aged individuals to proliferate and differentiate into cartilage. The purpose of this study was to investigate the optimal condition to culture human MSCs from the aged individuals (>50 years) for cartilage tissue engineering. We tested the hypothesis that effective proliferation and chondrogenesis can be achieved with human MSCs from aged individuals under appropriate conditions. To investigate the best condition for proliferation, MSCs were cultured in medium containing four concentrations subsets (0, 0.05, 0.5, 5 ng/mL) of recombinant human TGF-β 2 and FGF-2, either with or without fetal calf serum. The cell numbers were counted 0, 1, 3, and 7 days after growth factors were given. For the induction of chondrogenesis in 3-dimensional (3-D) culture, cells were cultured in pellets with chondrogenic medium containing combinations of various growth factors. After 4 weeks of culture, the pellets were fixed and evaluated with Safranin-O staining for proteoglycan and immunohistochemical staining for type II collagen. RT-PCR was also performed for the mRNAs of type I collagen, type II collagen, and cartilage oligomeric protein (COMP). In a monolayer culture, TGF-β 2 in concentrations of 0.5 and 5 ng/mL caused significant reduction in cell number irrespective of the presence of serum. FGF-2 of 5 ng/mL most effectively increased cell number even in the absence of serum. In a pellet culture, remarkable chondrocyte-like differentiation of cells was induced around the peripheral areas of a pellet with 5 ng/mL of TGF-β 2, accompanied by increased proteoglycan and type II collagen production. The addition of 100 ng/mL of IGF-I induced notable increase in proteoglycan contents. The results of RT-PCR mirrored those of histological studies. This study shows that an effective proliferation and chondrogenesis may be obtained with proper combinations of growth factors and mesenchymal stem cells from aged individuals.  This paper was cited by:Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: Greater doses of growth factor are necessary Hye-Joung Kim, Gun-Il Im Journal of Orthopaedic Research. Jun 2009, Vol. 27, No. 5: 612-619 CrossRef Insulin-like growth factor-I improves chondrogenesis of predifferentiated human umbilical cord mesenchymal stromal cells Limin Wang, Michael S. Detamore Journal of Orthopaedic Research. Feb 2009: n/a-n/a CrossRef High-Throughput Screening for Modulators of Mesenchymal Stem Cell Chondrogenesis Alice H. Huang, Nuzhat A. Motlekar, Ashley Stein, Scott L. Diamond, Eileen M. Shore, Robert L. Mauck Annals of Biomedical Engineering. Dec 2008, Vol. 36, No. 11: 1909-1921 CrossRef The Role of the Biochemical and Biophysical Environment in Chondrogenic Stem Cell Differentiation Assays and Cartilage Tissue Engineering Kristin E. Wescoe, Rebecca C. Schugar, Constance R. Chu, Bridget M. Deasy Cell Biochemistry and Biophysics. Nov 2008, Vol. 52, No. 2: 85-102 CrossRef Bone marrow mesenchymal stem cells in a hyaluronan scaffold for treatment of an osteochondral defect in a rabbit model S. Løken, R. B. Jakobsen, A. Årøen, S. Heir, A. Shahdadfar, J. E. Brinchmann, L. Engebretsen, F. P. Reinholt Knee Surgery, Sports Traumatology, Arthroscopy. Nov 2008, Vol. 16, No. 10: 896-903 CrossRef In Vitro Study on Interaction Between Human Nucleus Pulposus Cells and Mesenchymal Stem Cells Through Paracrine Stimulation Shu-Hua Yang, Chang-Chin Wu, Tiffany Ting-Fang Shih, Yuan-Hui Sun, Feng-Huei Lin Spine. Sep 2008, Vol. 33, No. 18: 1951-1957 CrossRef Technology Insight: adult mesenchymal stem cells for osteoarthritis therapy Ulrich Nöth, Andre F Steinert, Rocky S Tuan Nature Clinical Practice Rheumatology. Jun 2008 CrossRef Stem and progenitor cell therapies: recent progress for spinal cord injury repair J. Louro, D. D. Pearse Neurological Research. Mar 2008, Vol. 30, No. 1: 5-16 CrossRef Chondrogenic differentiation of amniotic fluid-derived stem cells Yash M. Kolambkar, Alexandra Peister, Shay Soker, Anthony Atala, Robert E. Guldberg Journal of Molecular Histology. Dec 2007, Vol. 38, No. 5: 405-413 CrossRef Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis Allison A. Stewart, Christopher R. Byron, Holly Pondenis, Matthew C. Stewart American Journal of Veterinary Research. Oct 2007, Vol. 68, No. 9: 941-945 CrossRef Articular cartilage repair: procedures versus products Craig Willers, Theo Partsalis, Ming-Hao Zheng Expert Review of Medical Devices. Jun 2007, Vol. 4, No. 3: 373-392 CrossRef
|
|